Advertisement
The Essential Resource for the Medical Design Engineering Community
Subscribe to MDT Magazine All

Genzyme stops making four U.S. drugs in Allston

November 24, 2010 5:34 am | by Mass High Tech: The Journal of New England Technology | News | Comments

Genzyme Corp. has stopped using its Allston plant for fill/finish operations of four drugs sold in the U.S., as part of an FDA consent decree.

Deburring PEEK Implants With Micro-Abrasive Blasting

November 24, 2010 5:19 am | Product Releases | Comments

Comco Inc.’s micro-abrasive blasting equipment can be used to deburr PEEK implants. Though PEEK’s biocompatibility and chemical resistant nature make it an ideal choice for medical implants, it creates challenges to the manufacturing process.

Diabetes drug could work against Alzheimer's

November 24, 2010 4:39 am | by EurekAlert | News | Comments

(Helmholtz Association of German Research Centres) Scientists from Berlin, Bonn and Dundee show in animal models that the diabetes drug metformin has an effect against one of the main causes of the Alzheimer's disease.

TOPICS:
Advertisement

Female fish -- and humans? -- lose interest when their male loses a slugfest

November 24, 2010 4:38 am | by EurekAlert | News | Comments

(Stanford University) If you see your special someone lose a competition, your subconscious may start whispering, "He's a loser," even as you insist your love is unaffected, according to Stanford researchers studying African cichlid fish. When female cichlids saw a favored suitor...

TOPICS:

Anti-AIDS groups hail drug but worry over cost

November 23, 2010 10:45 pm | by MARCUS WOHLSEN - Associated Press - Associated Press | News | Comments

AIDS prevention advocates are hailing a pill newly shown to protect against HIV as a great tool for disease prevention.But they caution that no drug alone can address social factors blamed for the persistence of the epidemic. And they say concerns remain about who will pay for the costly...

Health System’s Programs Merit ‘Blue’ Rating

November 23, 2010 10:34 pm | by San Diego Business Journal | News | Comments

The UC San Diego Health System has been designated as a Blue Distinction Center for Spine Surgery as well as for Knee and Hip Replacement.

TOPICS:

The Key Ingredient to Effective Cancer Treatments

November 23, 2010 7:34 pm | by Massachusetts Institute of Technology | News | Comments

A startup is developing oxygen-carrying compounds that it says could make radiation therapy more effective in half of all cancer patients.

Daily dose of HIV drug reduces risk of HIV infection

November 23, 2010 1:35 pm | by EurekAlert | News | Comments

(NIH/National Institute of Allergy and Infectious Diseases) A daily dose of an oral antiretroviral drug, currently approved to treat HIV infection, reduced the risk of acquiring HIV infection by 43.8 percent among men who have sex with men. The findings, a major advance in HIV...

TOPICS:
Advertisement

21 group leaders join network of EMBO Young Investigators

November 23, 2010 10:42 am | by EurekAlert | News | Comments

(European Molecular Biology Organization) Today, the European Molecular Biology Organization announced the selection of 21 of Europe's most talented young researchers as 2010 beneficiaries of the EMBO Young Investigator Programme.

TOPICS:

Cigarette smoking increases rheumatoid arthritis risk in African-Americans

November 23, 2010 10:42 am | by EurekAlert | News | Comments

(Wiley-Blackwell) A new study determined that African-Americans who smoke cigarettes have a higher risk of developing rheumatoid arthritis (RA). RA risk is more pronounced among individuals positive for the HLA-DRB1 shared epitope, a genetic risk factor for RA. Findings from this...

TOPICS:

Early diagnosis of rheumatoid arthritis crucial to positive outcomes for patients(2)

November 23, 2010 10:42 am | by EurekAlert | News | Comments

(Wiley-Blackwell) Positive outcomes in rheumatoid arthritis (RA) are closely linked to early diagnosis and treatment with disease-modifying antirheumatic drugs (DMARDs). A study by researchers in the Netherlands found that patients who are assessed by rheumatologists soon after RA...

TOPICS:

Aushon BioSystems appoints Beushausen as CSO

November 23, 2010 10:39 am | by Mass High Tech: The Journal of New England Technology | News | Comments

Aushon Biosytems Inc., a biotechnology services company, has named Sven Beushausen, a former molecular medicine site lead for Pfizer Inc., as its new chief scientific officer.

Study prescribes Medicare 2011 drug plan research

November 23, 2010 9:46 am | by TOM MURPHY - AP Business Writer - Associated Press | News | Comments

Medicare prescription drug customers should closely study 2011 coverage options before they renew their plans, according to the research firm Avalere Health, which forecasts significant changes in the coming year.Many plans have changed the drugs they cover or the amounts consumers pay, and...

TSX-listed corporate dividends and distributions declared Nov. 23, 2010

November 23, 2010 9:45 am | by The Associated Press | News | Comments

Dividends or distributions were declared or updated on the followed listed issues on the Toronto Stock Exchange on Nov. 23, 2010.Canadian Real Estate Investment Trust Units (TSX:REF.UN): $0.115. Payable Jun 14. Record May 31.Ag Growth International Inc. (TSX:AFN): $0.2. Payable Dec 30. Record...

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading